Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (741-750 of 1,253) with videos related to

Pageof 126
Sort By:
Clinical Trials (London, England)|June 16, 2023
Pragmatic guidance for embedding pragmatic clinical trials in health plans: Large simple trials aren't so simpleNoelle M Cocoros, Jerry H Gurwitz, Mark J Cziraky, et al.
European Heart Journal|April 1, 2008
Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic studySorin J Brener, David J Moliterno, Philip E Aylward, et al.
Journal of the American Heart Association|September 9, 2024
Relationship Between Infarct Artery, Myocardial Injury, and Outcomes After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial InfarctionSuzanne de Waha, Manesh R Patel, Holger Thiele, et al.
The American Journal of Cardiology|July 28, 2004
Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3)Jeptha P Curtis, John H Alexander, Yao Huang, et al.
European Heart Journal|April 19, 2013
Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trialSana M Al-Khatib, Laine Thomas, Lars Wallentin, et al.
European Heart Journal|July 20, 2002
Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes; the GUSTO-IIb haemostasis substudyK Kottke-Marchant, M C Bahit, C B Granger, et al.
Circulation|July 9, 2003
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarctionL Wallentin, P Goldstein, P W Armstrong, et al.
Circulation. Cardiovascular Quality and Outcomes|June 30, 2011
Care processes associated with quicker door-in-door-out times for patients with ST-elevation-myocardial infarction requiring transfer: results from a statewide regionalization programSeth W Glickman, Barbara L Lytle, Fang-Shu Ou, et al.
Contemporary Clinical Trials|August 7, 2013
Tailored Case Management for Diabetes and Hypertension (TEACH-DM) in a community population: study design and baseline sample characteristicsMatthew J Crowley, Hayden B Bosworth, Cynthia J Coffman, et al.
American Heart Journal|December 12, 2018
Patterns of use of targeted temperature management for acute myocardial infarction patients following out-of-hospital cardiac arrest: Insights from the National Cardiovascular Data RegistryChristopher B Fordyce, Anita Y Chen, Tracy Y Wang, et al.
Pageof 126

Showing results (741-750 of 1,253) with videos related to

Sort By:
Pageof 126
Clinical Trials (London, England)|June 16, 2023
Pragmatic guidance for embedding pragmatic clinical trials in health plans: Large simple trials aren't so simpleNoelle M Cocoros, Jerry H Gurwitz, Mark J Cziraky, et al.
European Heart Journal|April 1, 2008
Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic studySorin J Brener, David J Moliterno, Philip E Aylward, et al.
Journal of the American Heart Association|September 9, 2024
Relationship Between Infarct Artery, Myocardial Injury, and Outcomes After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial InfarctionSuzanne de Waha, Manesh R Patel, Holger Thiele, et al.
The American Journal of Cardiology|July 28, 2004
Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3)Jeptha P Curtis, John H Alexander, Yao Huang, et al.
European Heart Journal|April 19, 2013
Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trialSana M Al-Khatib, Laine Thomas, Lars Wallentin, et al.
European Heart Journal|July 20, 2002
Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes; the GUSTO-IIb haemostasis substudyK Kottke-Marchant, M C Bahit, C B Granger, et al.
Circulation|July 9, 2003
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarctionL Wallentin, P Goldstein, P W Armstrong, et al.
Circulation. Cardiovascular Quality and Outcomes|June 30, 2011
Care processes associated with quicker door-in-door-out times for patients with ST-elevation-myocardial infarction requiring transfer: results from a statewide regionalization programSeth W Glickman, Barbara L Lytle, Fang-Shu Ou, et al.
Contemporary Clinical Trials|August 7, 2013
Tailored Case Management for Diabetes and Hypertension (TEACH-DM) in a community population: study design and baseline sample characteristicsMatthew J Crowley, Hayden B Bosworth, Cynthia J Coffman, et al.
American Heart Journal|December 12, 2018
Patterns of use of targeted temperature management for acute myocardial infarction patients following out-of-hospital cardiac arrest: Insights from the National Cardiovascular Data RegistryChristopher B Fordyce, Anita Y Chen, Tracy Y Wang, et al.
Pageof 126